Cytokinetics CYTK
NASDAQ CYTK
$72.72 -1.23 (-1.66%)
As of: Sep 4, 2026 · 3:59 PM EDT

Cytokinetics (CYTK) Property, Plant & Equipment (Net) (QoQ) (2011 - 2026)

Analysis

Cytokinetics (CYTK) Property, Plant & Equipment (Net) (QoQ) (2011 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Cytokinetics 9.63 Bn 8.46 Bn 25.89 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -4.27%
Mar 31, 2026 4.10%
Dec 31, 2025 4.20%
Sep 30, 2025 8.23%
Jun 30, 2025 4.53%
Mar 31, 2025 2.07%
Dec 31, 2024 2.48%
Sep 30, 2024 -2.23%
Jun 30, 2024 -3.42%
Mar 31, 2024 -1.06%
Dec 31, 2023 -9.08%
Sep 30, 2023 -2.12%
Jun 30, 2023 -2.04%
Mar 31, 2023 -1.98%
Dec 31, 2022 0.19%
Sep 30, 2022 2.18%
Jun 30, 2022 3.76%
Mar 31, 2022 3.37%
Dec 31, 2021 35.95%
Sep 30, 2021 45.89%